These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1944913)

  • 1. Dihydropteridine reductase activity: lack of association with serum aluminum levels and cognitive functioning in patients with end-stage renal disease.
    Bolla KI; Milstien S; Briefel G; Wieler L; Kaufman S
    Neurology; 1991 Nov; 41(11):1806-9. PubMed ID: 1944913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum aluminum levels and erythrocyte dihydropteridine reductase activity in patients on hemodialysis.
    Altmann P; Al-Salihi F; Butter K; Cutler P; Blair J; Leeming R; Cunningham J; Marsh F
    N Engl J Med; 1987 Jul; 317(2):80-4. PubMed ID: 3587329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aluminum exposure on pteridine metabolism.
    Baydar T; Engin AB; Aydin A; Sahin G
    Biol Trace Elem Res; 2005 Aug; 106(2):153-64. PubMed ID: 16116247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydropteridine reductase in schizophrenic patients.
    Szymanski HV; Orfanos A; Narisawa K; Grosz R; Naylor EW
    Psychiatry Res; 1985 Jun; 15(2):115-9. PubMed ID: 3862143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disturbance of cerebral function by aluminium in haemodialysis patients without overt aluminium toxicity.
    Altmann P; Dhanesha U; Hamon C; Cunningham J; Blair J; Marsh F
    Lancet; 1989 Jul; 2(8653):7-12. PubMed ID: 2567838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydropteridine reductase activity in dried blood spots: effects of aging and senile dementia of the Alzheimer type.
    Jeeps CM; Silcox A; Lloyd B; Clayton BE
    J Clin Pathol; 1986 Feb; 39(2):199-203. PubMed ID: 3950042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis, treatment and gene mutation analysis of the first case with dihydropteridine reductase deficiency in the mainland of China].
    Ye J; Qiu WJ; Han LS; Zhang HW; Zhou JD; Gao XL; Wang Y; Gu XF
    Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):281-5. PubMed ID: 19099731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The estimation of dihydropteridine reductase in human blood cells.
    Webber S; Hural JA; Whiteley JM
    Clin Chim Acta; 1988 Apr; 173(2):117-26. PubMed ID: 3378353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydropteridine reductase activity and neopterin levels in leukemias and lymphomas: is there any correlation between these two parameters?
    Altindag ZZ; Sahin G; Işimer A; Akpek G; Kansu E
    Leuk Lymphoma; 1999 Oct; 35(3-4):367-74. PubMed ID: 10706461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DHPR activity decrease in dried blood spots stored at 4 degrees C.
    Lenzi G; Pistone D; Zammarchi E; Benini MP; La Torre A; Matteoni D
    Enzyme; 1989; 41(1):43-6. PubMed ID: 2731491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperphenylalaninemia due to dihydropteridine reductase deficiency: diagnosis by enzyme assays on dried blood spots.
    Arai N; Narisawa K; Hayakawa H; Tada K
    Pediatrics; 1982 Sep; 70(3):426-30. PubMed ID: 7110817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Measurement of dihydropteridine reductase activity in dried blood eluates: physiological and pathological implications].
    Dhondt JL
    Ann Biol Clin (Paris); 1992; 50(9):653-8. PubMed ID: 1298171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the metals on dihydropteridine reductase activity.
    Altindag ZZ; Baydar T; Engin AB; Sahin G
    Toxicol In Vitro; 2003; 17(5-6):533-7. PubMed ID: 14599441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cell aluminum in patients with renal failure and effect of desferrioxamine infusion.
    Umeda M; Tsurusaki K; Kamikawa S; Izumi N; Yasumoto R; Kishimoto T; Maekawa M
    Blood Purif; 1990; 8(5):295-300. PubMed ID: 2091689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical (mild) forms of dihydropteridine reductase deficiency: neurochemical evaluation and mutation detection.
    Blau N; Heizmann CW; Sperl W; Korenke GC; Hoffmann GF; Smooker PM; Cotton RG
    Pediatr Res; 1992 Dec; 32(6):726-30. PubMed ID: 1283784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and expression of human dihydropteridine reductase.
    Lockyer J; Cook RG; Milstien S; Kaufman S; Woo SL; Ledley FD
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3329-33. PubMed ID: 3033643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NADH-ferric reductase activity associated with dihydropteridine reductase.
    Lee PL; Halloran C; Cross AR; Beutler E
    Biochem Biophys Res Commun; 2000 May; 271(3):788-95. PubMed ID: 10814540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aluminum and dihydropteridine reductase in Alzheimer's disease].
    Fuchs D; Werner ER; Wachter H
    Dtsch Med Wochenschr; 1988 May; 113(21):877. PubMed ID: 3371217
    [No Abstract]   [Full Text] [Related]  

  • 19. Aluminum accumulation in children on chronic dialysis: predictive value of serum aluminum levels and desferrioxamine infusion test.
    Roodhooft AM; van de Vyver FL; D'Haese PC; van Acker KJ; Visser WJ; de Broe ME
    Clin Nephrol; 1987 Sep; 28(3):125-9. PubMed ID: 3665205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aluminium determination in the skin of patients with and without end-stage renal failure.
    Subra JF; Krari N; Tirot P; Mauras Y; Balit G; Van-Weydevelt FC; Allain P
    Nephron; 1991; 58(2):170-3. PubMed ID: 1865973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.